PHC Holdings Corporation (PHCCF)
| Market Cap | 1.13B +32.7% |
| Revenue (ttm) | 2.28B +3.0% |
| Net Income | 56.42M -19.0% |
| EPS | 0.46 -19.3% |
| Shares Out | n/a |
| PE Ratio | 19.57 |
| Forward PE | n/a |
| Dividend | 0.27 (2.99%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 15,400 |
| Open | 9.51 |
| Previous Close | 9.26 |
| Day's Range | 8.91 - 9.51 |
| 52-Week Range | 6.28 - 10.68 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |
About PHC Holdings
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and... [Read more]
Financial Performance
In fiscal year 2026, PHC Holdings's revenue was 364.40 billion, an increase of 0.78% compared to the previous year's 361.59 billion. Earnings were 492.00 million, a decrease of -95.31%.
Financial numbers in JPY Financial StatementsNews
PHC Holdings Earnings Call Transcript: Q1 2027
Revenue and profitability improved across all regions, led by strong Diabetes Management and diagnostics sales, with margin gains and cost efficiencies. Management expects to maintain momentum and may revise guidance upward if trends persist.
PHC Holdings Quarterly report: Q1 2027
PHC Holdings has published its Q1 2027 quarterly earnings report on August 6, 2026.
PHC Holdings Slides: Q1 2027
PHC Holdings has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 6, 2026.
PHC Holdings Earnings Call Transcript: Q4 2026
FY 2025 saw record revenue and operating profit, driven by strong BGM performance and cost improvements, despite FX losses. FY 2026 targets profit growth, stable dividends, and continued restructuring, with risks from FX volatility and U.S. market demand.
PHC Holdings Quarterly report: Q4 2026
PHC Holdings has published its Q4 2026 quarterly earnings report on May 13, 2026.
PHC Holdings Slides: Q4 2026
PHC Holdings has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 13, 2026.
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
RUNCORN, United Kingdom--(BUSINESS WIRE)-- #AI--Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), and Mindpeak, a leading provider of a...
PHC Holdings Earnings Call Transcript: Q3 2026
Q3 saw strong BGM and diabetes management growth, offsetting declines in diagnostics and life sciences, with FX losses impacting net profit. Full-year guidance remains unchanged, with a conservative Q4 outlook due to market risks and inventory adjustments.
PHC Holdings Quarterly report: Q3 2026
PHC Holdings has published its Q3 2026 quarterly earnings report on February 12, 2026.
PHC Holdings Slides: Q3 2026
PHC Holdings has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 12, 2026.
PHC Holdings Earnings Call Transcript: Q2 2026
Operating profit forecast was revised upward despite FX losses and persistent US tariff impacts. BGM margins improved on price hikes and cost controls, while diagnostics and life sciences face ongoing headwinds. CGM business transfer is on track, with no impairment loss recognized.
PHC Holdings Quarterly report: Q2 2026
PHC Holdings has published its Q2 2026 quarterly earnings report on November 12, 2025.
PHC Holdings Slides: Q2 2026
PHC Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 12, 2025.